Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria.
Saved in:
| Title: | Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria. |
|---|---|
| Authors: | Kane JM; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA. Electronic address: jkane2@northwell.edu., Harary E; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Eshet R; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Tohami O; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Weiser M; Sheba Medical Center, Department of Psychiatry, Tel Hashomer, Israel; Sackler School of Medicine at Tel Aviv University, Department of Psychiatry, Tel Aviv, Israel., Leucht S; Technical University of Munich, School of Medicine, Department of Psychiatry and Psychotherapy, Munich, Germany., Merenlender-Wagner A; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Sharon N; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel., Davis GL 3rd; Teva Branded Pharmaceutical Products R&D, Global Clinical Operations, West Chester, PA, USA., Suett M; Teva UK, Global Medical Affairs, Harlow, UK., Franzenburg KR; Teva Branded Pharmaceutical Products R&D, Global Medical Affairs, West Chester, PA, USA., Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA; Charité-Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany. |
| Source: | The lancet. Psychiatry [Lancet Psychiatry] 2023 Dec; Vol. 10 (12), pp. 934-943. Date of Electronic Publication: 2023 Nov 02. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101638123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2215-0374 (Electronic) Linking ISSN: 22150366 NLM ISO Abbreviation: Lancet Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37924833 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kane+JM%22">Kane JM</searchLink>; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA. Electronic address: jkane2@northwell.edu.<br /><searchLink fieldCode="AU" term="%22Harary+E%22">Harary E</searchLink>; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel.<br /><searchLink fieldCode="AU" term="%22Eshet+R%22">Eshet R</searchLink>; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel.<br /><searchLink fieldCode="AU" term="%22Tohami+O%22">Tohami O</searchLink>; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel.<br /><searchLink fieldCode="AU" term="%22Weiser+M%22">Weiser M</searchLink>; Sheba Medical Center, Department of Psychiatry, Tel Hashomer, Israel; Sackler School of Medicine at Tel Aviv University, Department of Psychiatry, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Leucht+S%22">Leucht S</searchLink>; Technical University of Munich, School of Medicine, Department of Psychiatry and Psychotherapy, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Merenlender-Wagner+A%22">Merenlender-Wagner A</searchLink>; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel.<br /><searchLink fieldCode="AU" term="%22Sharon+N%22">Sharon N</searchLink>; Teva Pharmaceutical Industries, Global Specialty Research & Development, Netanya, Israel.<br /><searchLink fieldCode="AU" term="%22Davis+GL+3rd%22">Davis GL 3rd</searchLink>; Teva Branded Pharmaceutical Products R&D, Global Clinical Operations, West Chester, PA, USA.<br /><searchLink fieldCode="AU" term="%22Suett+M%22">Suett M</searchLink>; Teva UK, Global Medical Affairs, Harlow, UK.<br /><searchLink fieldCode="AU" term="%22Franzenburg+KR%22">Franzenburg KR</searchLink>; Teva Branded Pharmaceutical Products R&D, Global Medical Affairs, West Chester, PA, USA.<br /><searchLink fieldCode="AU" term="%22Correll+CU%22">Correll CU</searchLink>; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA; Charité-Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101638123%22">The lancet. Psychiatry</searchLink> [Lancet Psychiatry] 2023 Dec; Vol. 10 (12), pp. 934-943. <i>Date of Electronic Publication: </i>2023 Nov 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101638123 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2215-0374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222150366%22">22150366 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Psychiatry <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37924833 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S2215-0366(23)00288-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 934 Titles: – TitleFull: Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kane JM – PersonEntity: Name: NameFull: Harary E – PersonEntity: Name: NameFull: Eshet R – PersonEntity: Name: NameFull: Tohami O – PersonEntity: Name: NameFull: Weiser M – PersonEntity: Name: NameFull: Leucht S – PersonEntity: Name: NameFull: Merenlender-Wagner A – PersonEntity: Name: NameFull: Sharon N – PersonEntity: Name: NameFull: Davis GL 3rd – PersonEntity: Name: NameFull: Suett M – PersonEntity: Name: NameFull: Franzenburg KR – PersonEntity: Name: NameFull: Correll CU IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2023 Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2215-0374 Numbering: – Type: volume Value: 10 – Type: issue Value: 12 Titles: – TitleFull: The lancet. Psychiatry Type: main |
| ResultId | 1 |
